Comments
Aurobindo Pharma Ltd has posted a consolidated net profit of Rs 18.6 crore in the first quarter ended June 30, 2013.
In the corresponding quarter of the previous financial year, the Hyderabad-based firm suffered a net loss of Rs 129 crore. Revenues increased to Rs 1,699 crore (Rs 1,197 crore).
“Our focus on costs and the qualitative aspect of sales across key markets have reflected positively on our revenues and operating margins on a year-on-year basis,’’ Aurobindo Pharma Managing Director N. Govindarajan said in a release.
The net profit was impacted by the mark-to-market component of its dollar-denominated debt because of the rupee depreciation during the quarter, he added.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.